LeadIQ logo
Learn more at LeadIQ.com

Insights

Strategic Corporate Hires Passage Bio's recent appointment of Tom Kassberg and Dolan Sondhi to its Board of Directors and Nominating and Corporate Governance Committee respectively indicate opportunities to engage with leadership for potential partnership discussions.

Academic Partnership Initiative The launch of the Tachi Yamada Scholarship Program by Passage Bio demonstrates a focus on academia and education. This presents an ideal avenue to pitch collaborative research projects or sponsorship opportunities to support future scientific breakthroughs.

Clinical Trial Outcomes The positive interim clinical data released by Passage Bio from its trials present a window of opportunity to engage in discussions related to potential collaboration, licensing, or supply agreements based on the promising results.

Financial Stability & Growth With a revenue range of $10-50 million and funding of $154 million, Passage Bio showcases financial stability. This opens up opportunities for engaging in discussions around investment, joint ventures, or other financial partnerships.

Focus on CNS Therapies As a company focused on developing transformative therapies for central nervous system (CNS) disorders, Passage Bio's alignment with this specific healthcare segment presents a golden opportunity for collaboration on CNS-focused research, development, or commercialization projects.

Similar companies to Passage Bio

Passage Bio Tech Stack

Passage Bio uses 8 technology products and services including Backbone.js, RequireJS, Mustache, and more. Explore Passage Bio's tech stack below.

  • Backbone.js
    Javascript Frameworks
  • RequireJS
    Javascript Frameworks
  • Mustache
    Javascript Frameworks
  • Windows Server
    Operating Systems
  • New Relic
    Real User Monitoring
  • FedEx
    Transportation And Fleet Management
  • UPS
    Transportation And Fleet Management
  • Nginx
    Web Servers

Media & News

Passage Bio's Email Address Formats

Passage Bio uses at least 1 format(s):
Passage Bio Email FormatsExamplePercentage
FLast@passagebio.comJDoe@passagebio.com
49%
First.Last@passagebio.comJohn.Doe@passagebio.com
1%
Last@passagebio.comDoe@passagebio.com
1%
FLast@passagebio.comJDoe@passagebio.com
49%

Frequently Asked Questions

Where is Passage Bio's headquarters located?

Minus sign iconPlus sign icon
Passage Bio's main headquarters is located at 2005 Market Street 39th Floor Philadelphia, Pennsylvania 19103 US. The company has employees across 3 continents, including North AmericaEuropeSouth America.

What is Passage Bio's stock symbol?

Minus sign iconPlus sign icon
Passage Bio is a publicly traded company; the company's stock symbol is PASG.

What is Passage Bio's official website and social media links?

Minus sign iconPlus sign icon
Passage Bio's official website is passagebio.com and has social profiles on LinkedIn.

How much revenue does Passage Bio generate?

Minus sign iconPlus sign icon
As of September 2024, Passage Bio's annual revenue reached $35M.

What is Passage Bio's SIC code NAICS code?

Minus sign iconPlus sign icon
Passage Bio's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Passage Bio have currently?

Minus sign iconPlus sign icon
As of September 2024, Passage Bio has approximately 82 employees across 3 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: W. C.Chief Technical Officer: A. F.Chief Scientific Officer: S. B.. Explore Passage Bio's employee directory with LeadIQ.

What industry does Passage Bio belong to?

Minus sign iconPlus sign icon
Passage Bio operates in the Biotechnology Research industry.

What technology does Passage Bio use?

Minus sign iconPlus sign icon
Passage Bio's tech stack includes Backbone.jsRequireJSMustacheWindows ServerNew RelicFedExUPSNginx.

What is Passage Bio's email format?

Minus sign iconPlus sign icon
Passage Bio's email format typically follows the pattern of . Find more Passage Bio email formats with LeadIQ.

How much funding has Passage Bio raised to date?

Minus sign iconPlus sign icon
As of September 2024, Passage Bio has raised $154M in funding. The last funding round occurred on Jan 21, 2021 for $154M.

When was Passage Bio founded?

Minus sign iconPlus sign icon
Passage Bio was founded in 2017.
Passage Bio

Passage Bio

Biotechnology ResearchPennsylvania, United States51-200 Employees

We are a clinical stage genetic medicines company on a mission to improve the lives of patients with neurodegenerative diseases. Our primary focus is the development and advancement of cutting-edge, one-time therapies designed to target the underlying pathology of these conditions. 

Our lead product candidate, PBFT02, seeks to treat neurodegenerative conditions, including frontotemporal dementia, by elevating progranulin levels to restore lysosomal function and slow disease progression. Our team's unwavering commitment to excellence is the driving force behind our mission to protect patients and their families against loss in neurodegenerative conditions.

Section iconCompany Overview

Headquarters
2005 Market Street 39th Floor Philadelphia, Pennsylvania 19103 US
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
PASG
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $154M

    Passage Bio has raised a total of $154M of funding over 3 rounds. Their latest funding round was raised on Jan 21, 2021 in the amount of $154M.

  • $10M$50M

    Passage Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $154M

    Passage Bio has raised a total of $154M of funding over 3 rounds. Their latest funding round was raised on Jan 21, 2021 in the amount of $154M.

  • $10M$50M

    Passage Bio's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.